Targeting Mitochondrial dysfunction in schizophrenia: The NDUFV2 Pseudogene Threat
Source PublicationScientific Publication
Primary AuthorsBen-Shachar, Lapiro, Karry et al.
"Imagine a factory powered by a main generator. The pseudogene acts like a rogue radio signal that scrambles the generator's operating instructions, causing severe power outages. Blocking the rogue signal restores full power to the factory floor."

Problem: Mitochondrial dysfunction in schizophrenia
Bottom line: Suppressing a rogue pseudogene restores cellular energy and neuronal activity in laboratory models of severe mental illness. This offers a direct biological target for treatment. Mitochondrial dysfunction in schizophrenia represents a core biological failure. Patients experience severe disruptions in emotion, cognition, and social behaviour. Neurons demand massive energy to function. Mitochondria provide this energy. In schizophrenia, these powerhouses fail. A primary suspect is Complex I, specifically its NDUFV2 core-subunit. Researchers noted an anomaly. A pseudogene known as NDUFV2P1 is highly upregulated in both the brain and peripheral cells of patients. This overabundance inversely correlates with healthy mitochondrial respiration. The machinery breaks down. This energy deficit compromises synaptic plasticity, which is required for learning and memory. When the supply drops, high-demand neural circuits fail.
Solution: Modulating Genetic Interference
To test whether this pseudogene actively causes the damage, investigators manipulated its levels in Epstein-Barr-virus-transformed lymphocyte cell lines. The results were definitive. When they overexpressed the pseudogene in cells derived from healthy individuals, the cellular power grid collapsed. Oxygen consumption plummeted. Mitochondrial network dynamics degraded. Conversely, researchers applied the opposite approach to cells derived from patients with schizophrenia. They downregulated the pseudogene. The cells recovered. Oxygen consumption and mitochondrial membrane potential returned to normal baseline levels. The intervention directly repaired the bioenergetic fault.
Mechanism: Suppressing the Core Subunit
The study measured specific physical and chemical changes. In-silico analyses excluded small RNA interference, pointing directly to the pseudogene itself as the active disruptive agent. It suppresses the required NDUFV2 expression. To understand the brain-specific effects, the team moved to rat cortical neurons. Overexpressing the pseudogene in these specific laboratory models induced severe structural and functional penalties. Synapse formation stalled. Spontaneous neuronal firing dropped significantly. The neurons could no longer communicate effectively. Without adequate power from Complex I, the neural networks simply cannot sustain normal activity. The data suggests that this genetic interference directly links cellular energy deficits to the macroscopic symptoms of the disorder.
Impact: Strategic Implications for Psychiatry
This research isolates a highly specific mechanical failure in psychiatric illness. By targeting the bioenergetic supply chain, we might treat the underlying cellular exhaustion. The study measured successful restoration of mitochondrial function in laboratory models. This indicates that downregulating the NDUFV2P1 pseudogene could serve as a viable therapeutic strategy for bioenergetic impairments. If these cellular repairs eventually translate to human clinical outcomes, correcting energy deficits may alleviate the cognitive and social impairments associated with the disorder. The focus shifts from managing symptoms to restoring fundamental cellular power.